A*STAR Bioprocessing Technology Institute (BTI) has been advancing bioprocessing technologies and research for 35 years. Guided by its vision to realise quality processes for biomanufacturing, BTI focuses on proteins, cells and nucleic acids, developing innovative research capabilities and technologies to strengthen Singapore's biomanufacturing sector.
To achieve its vision of ensuring quality processes for biomanufacturing, BTI develops innovative research capabilities and advanced biomanufacturing technologies.
Modality-specific strategies across proteins, cells and nucleic acids enable BTI to address technologies at different stages of maturity and support the development of Singapore's biomanufacturing sector.
507d96120ba443ccb681adb338e5a4cc.png?width=700&height=500)
BTI's core capabilities are organised across four principal divisions, overseeing 19 Enabling Research Groups, Technology Platforms and Consortia. This matrix structure enables the swift and flexible assembly of multidisciplinary research teams with complementary expertise to address research challenges and industry needs.
.png)
.jpg)
